Hello fellow board members, hope everyone is safe. Here is what we have to look forward to in the next few weeks:
1. Release of EHA abstracts, should be in first week of May
2. Results of FDA meeting, should be around mid May
3. Annual shareholders meeting June 5th
4. EHA virtual meetings second week of June.
GLTA, bp
Near term events
Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
-
- Posts: 1670
- Joined: Fri Jul 20, 2018 5:13 pm
Re: Near term events
Correction: EHA Abstract release May 14th.
Re: Near term events
What’s left of the optimism and patience I have left, is being exuded for these next 4-6 weeks.
A decade of groundbreaking preclinical work + early and mid-stage trials, which have shown an acceptable safety profile along with efficacious effects for patients, makes the path of Imetelstat primed for success in treating patients. I think it is more of a question of when rather than if for these initial heme indications of MF and MDS. That time is now or 2023.
- I’m really banking of now.
A decade of groundbreaking preclinical work + early and mid-stage trials, which have shown an acceptable safety profile along with efficacious effects for patients, makes the path of Imetelstat primed for success in treating patients. I think it is more of a question of when rather than if for these initial heme indications of MF and MDS. That time is now or 2023.
- I’m really banking of now.
-
- Posts: 1670
- Joined: Fri Jul 20, 2018 5:13 pm
Re: Near term events
Me too, brother. As the Ram Bam said, if not now, when?